We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Organic Compound Stimulates Skin Regeneration in Burns

By HospiMedica International staff writers
Posted on 22 Jul 2015
A novel polymer derived from gallic acid could help promotes skin regeneration in third-degree burn patients, according to a new study.

Developed by researchers at the National University of Mexico (UNAM; Mexico City), the new, water-soluble polymer, named gallic polyacid, has antimicrobial and antioxidant capacities that could be implemented in a range of applications, including wound management for diabetics, medical patches for skin regeneration, and as a semiconductor component of electrochromic cells, such as those used in smart polychromic windows. More...
Other possible applications include use as an additive for free endocrine disruption, and in biodegradable food packaging.

The researchers are currently performing laboratory test in collaboration with the National Institute for Rehabilitation (INR; Mexico City, Mexico) in the creation of cellulose films loaded with gallic polyacid that could stimulate regeneration of the skin in patients with third-degree burns, where the polymer can act as an agent against bacteria populating ulcerating wounds. According to the researchers, this is made possible by anchoring the gallic polyacid molecule to other biopolymers with film-forming ability.

“We succeeded via a defined molecular structure to achieve improved biological availability. It has antioxidant and antimicrobial and qualities, which are useful in biomedicine and food,” said Miquel Gimeno Seco, PhD, head of research at the UNAM school of chemistry. “Being soluble, the molecule could be incorporated into the affected area, acting against resistant bacteria. One of the challenges [facing us] is to ensure that natural materials are efficient and cheap as inorganic catalysts.”

Gallic acid is a colorless crystalline organic powder that occurs as a free molecule or as part of a tannin molecule. It is found in almost all plants, with especially high content in gallnuts, grapes, tea, hops, blueberries, and oak bark. Gallic acid seems to have antifungal, antiviral, and antibacterial properties, and has been found to show cytotoxicity against cancer cells, without harming healthy cells. Other uses include serving as an astringent in internal hemorrhage ad in ointments to treat psoriasis and external hemorrhoids.

Related Links:

National University of Mexico
National Institute for Rehabilitation



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.